Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain
Current Medical Research and Opinion, 09/08/09
Mayordomo JI et al. – FN substantially affects healthcare resource use and costs in breast cancer, lung cancer and, NHL. In this study, hospitalization and antibiotics were the main drivers of cost. A limitation of the analysis was that it did not include the indirect costs associated with FN episodes.
Related Articles
Diagnostic performance of cardiac magnetic resonance imaging in coronary artery disease
Clinical Physiology and Functional Imaging, 11/11/09
Relevance Score: 84%
Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance
Arthritis & Rheumatism, 11/09/09
Relevance Score: 84%
Detection of Myocardial Damage in Patients With Sarcoidosis
Circulation, 11/05/09
Relevance Score: 84%
Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: An in vivo cardiovascular magnetic resonance study
Catheterization and Cardiovascular Interventions, 10/30/09
Relevance Score: 80%
Cardiac function by MRI in congenital heart disease: Impact of consensus training on interinstitutional variance
Journal of Magnetic Resonance Imaging, 10/29/09
Relevance Score: 80%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Drug Approval Summary: Bevacizumab (Avastin) as Treatment of Recurrent Glioblastoma Multiforme
The Oncologist, 12/02/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
Clinical Cancer Research, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


